A best evidence topic in thoracic surgery was written according to a structured protocol. The question addressed was how video-assisted thoracoscopic surgery (VATS) compares to median sternotomy in the surgical management of patients with myasthenia gravis (MG)? Overall 74 papers were found using the reported search, of which 15 represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results are tabulated. We conclude that VATS produces equivalent postoperative mortality and complete stable remission (CSR) rates, with superior results in terms of hospital stay, operative blood loss and patient satisfaction at the expense of a doubling of operative time. Six studies comparing VATS and transsternal sternotomy in non-thymomatous myasthenia gravis (NTMG) patients found VATS to have lower operative blood loss (73.8"70.7 vs. 155.3"91.7 ml; P-0.05), reduced total hospital stay (5.6"2.2 vs. 8.1"3.0 days; Ps0.008), whilst maintaining equivalent remission rates (33 vs. 44.7%; Ps0.16) and mass of thymic tissue resection (37 vs. 34 g; P)0.05). One study comparing video-assisted thoracoscopic extended thymectomy to transsternal thymectomy in only thymoma-associated myasthenia gravis (T-MG) patients found equivalent CSR (11.3 vs. 8.7%, Ps0.1090) at six-year follow-up. Thymoma recurrence rate (9.64%) was not significantly different (Ps0.1523) between the two groups. Eight studies comparing VATS and transsternal approach in mixed T-MG and NTMG patients found a lower hospital stay (1.9"2.6 vs. 4.6"4.2 days, P-0.001), reduced need for postoperative medication (76.5 vs. 35.7%, Ps0.022), lower intensive care unit stay (1.5 vs. 3.2 days, Ps0.018), greater symptom improvement (100 vs. 77.9%, Ps0.019) and better cosmetic satisfaction (100 vs. 83, Ps0.042) with VATS. In concordance with NTMG and T-MG alone patient groups, VATS and transsternal methods had equivalent complication rates (23 vs. 19%, Ps0.765) with no mortalities in either group. Even though VATS has a longer operative time (268"51 vs. 177"92 min, P-0.05), its improved cosmesis, reduced need for postoperative medication and equivalent disease resolution outcomes make it a preferable surgical option to the transsternal approach.
Introduction
A best evidence topic was constructed according to a structured protocol. This is fully described in ICVTS w1x.
Three-part question
In wpatients undergoing thymectomy for myasthenia gravisx is wvideo-assisted thoracoscopic surgeryx equivalent to wtranssternal sternotomyx in terms of wmorbidity and disease resolutionx.
Clinical scenario
You see a 26-year-old female in out-patients clinic with a recent diagnosis of Osserman Class IV myasthenia gravis (MG). Her symptoms are poorly controlled on her current medication and you feel surgical intervention is required. She is very concerned about surgery, especially about the length of time she will have to take off work and the *Corresponding author. Tel.: q44 75 15542899; fax: q44 20 71881016. E-mail address: marco.scarci@mac.com (M. Scarci). disfiguring scars it may leave. You feel that thymectomy by the video-assisted thoracoscopic approach may result in a shorter hospital stay and be more aesthetically pleasing than a median sternotomy. You carry out a review of the literature.
Search strategy
Medline search 1950 to August 2010 was performed using the OVID interface wexp ThoracoscopyyOR Thoracoscop$.mp OR VATS.mpx AND wexp myastheniayOR myasthenia.mpx AND wexp sternotomyyOR sternotomy.mp OR transsternal.mpx
Search outcome
Seventy-four papers were found using the reported search. From these 15 papers were identified that provided the best evidence to answer the question. These are presented in Table 1 .
In addition, the reference list of each paper was searched. I. Zahid et al. / Interactive CardioVascular and Thoracic Surgery 12 (2011) 
Results
We must firstly acknowledge that the presence of thymoma within the thymus gland may affect the most appropriate surgical treatment option for a patient with MG.
Six studies looked at patients with non-thymomatous myasthenia gravis (NTMG) only. Shiono et al. w2x reviewed 58 patients, who underwent either bilateral video-assisted thoracoscopic extended thymectomy (VATET) (ns32) or median sternotomy (ns26). Remission rates at one-year (12.5 vs. 8.5%) and mass of thymic tissue resected (37 g vs. 33 , Ps0.369) were equivalent in the two groups. Operative blood loss (60 vs. 340 ml, P-0.001) was lower for VATET despite its longer operative time (230 vs. 170 min, P-0.001).
Mantegazza et al. w3x reported that VATET and transsternal thymectomy had equivalent complete stable remission (CSR) rates at six-year follow-up (53y159 vs. 21y47, Ps0.16). Mean operative time for the last 20 VATETs (75.6"17.2 min) was much less (P-0.0001) than the first 20 VATETs (160"58.6 min) and the transsternal approach.
Most recently, Ng et al. w4x conducted a meta-analysis of 15 studies involving 1003 patients, which compared VATS (ns533), transcervical (ns449) and the infrasternal mediastinoscopic (ns21) approach. VATS (35.4%) and transcervical (38.1%) had comparable remission rates at 10-year follow-up.
Rückert et al. w5x reported their experience (ns182) for VATS, transsternal and anterolateral approaches, showing equivalent CSR (12% vs. 18% vs. 17%) and activities of daily living (ADL) scores (6 vs. 5.5 vs. 7.5, P-0.05). Morbidity rates were the lowest in VATS (5 vs. 25% vs. 15%, P-0.05) despite the longer operative time (197 vs. 113 vs. 82 min, P-0.001 
Clinical bottom line
Surgical management of MG is becoming increasingly recognised as an effective treatment option. Currently no consensus is in place on which surgical method is first line. The studies above have shown that VATS produces equivalent postoperative mortality and CSR, with many papers demonstrating superior results in terms of hospital stay, operative blood loss and patient satisfaction compared to the transsternal approach. Hence, VATS may be considered in preference to the transsternal approach despite its greater operative times.
